150 related articles for article (PubMed ID: 2645372)
1. Immunohistologic evidence for the malignant potential of congenital melanocytic nevi.
Steijlen PM; Hamm H; van Erp EJ; Johnson JP; Ruiter DJ; Bröcker EB
J Invest Dermatol; 1989 Mar; 92(3):366-70. PubMed ID: 2645372
[TBL] [Abstract][Full Text] [Related]
2. Congenital melanocytic nevi and DNA content. An analysis by flow and image cytometry.
Barnhill RL; Aguiar M; Cohen C; Kang S; Kennedy J; Schmidt B; Sober AJ; Solomon AR
Cancer; 1994 Dec; 74(11):2935-43. PubMed ID: 7954257
[TBL] [Abstract][Full Text] [Related]
3. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
4. Genetic changes in neoplasms arising in congenital melanocytic nevi: differences between nodular proliferations and melanomas.
Bastian BC; Xiong J; Frieden IJ; Williams ML; Chou P; Busam K; Pinkel D; LeBoit PE
Am J Pathol; 2002 Oct; 161(4):1163-9. PubMed ID: 12368190
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions.
Rudolph P; Lappe T; Schubert C; Schmidt D; Parwaresch RM; Christophers E
Am J Pathol; 1995 Dec; 147(6):1615-25. PubMed ID: 7495287
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi.
Gill P; Prieto VG; Austin MT; Giubellino A; Torres-Cabala CA
J Cutan Pathol; 2021 Nov; 48(11):1410-1415. PubMed ID: 34164835
[TBL] [Abstract][Full Text] [Related]
7. The differential reactivity of benign and malignant nevomelanocytic lesions with mouse monoclonal antibody TNKH1.
Nakanishi T; Hashimoto K
Cancer; 1987 Apr; 59(7):1340-4. PubMed ID: 3545436
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of human monoclonal antibody (2-139-1) in cutaneous melanocytic neoplasms in fixed tissue sections.
White WL; Tam ST; Mitchell MS; Yu MC; Kan-Mitchell J
J Histochem Cytochem; 1991 Jun; 39(6):777-85. PubMed ID: 1709658
[TBL] [Abstract][Full Text] [Related]
9. Proliferative nodules in congenital melanocytic nevi: a clinicopathologic and immunohistochemical analysis.
Herron MD; Vanderhooft SL; Smock K; Zhou H; Leachman SA; Coffin C
Am J Surg Pathol; 2004 Aug; 28(8):1017-25. PubMed ID: 15252307
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical demonstration of S-100 protein and melanoma-associated antigens in melanocytic nevi.
Paul E; Cochran AJ; Wen DR
J Cutan Pathol; 1988 Jun; 15(3):161-5. PubMed ID: 2456315
[TBL] [Abstract][Full Text] [Related]
11. Development of MoAb HMSA-2 for melanosomes of human melanoma and its application to immunohistopathologic diagnosis of neoplastic melanocytes.
Maeda K; Jimbow K
Cancer; 1987 Feb; 59(3):415-23. PubMed ID: 3539311
[TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies selected to discriminate between malignant melanomas and nevocellular nevi.
Ruiter DJ; Dingjan GM; Steijlen PM; van Beveren-Hooyer M; de Graaff-Reitsma C; Bergman W; van Muijen GN; Warnaar SO
J Invest Dermatol; 1985 Jul; 85(1):4-8. PubMed ID: 3891875
[TBL] [Abstract][Full Text] [Related]
13. Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanoma.
D'Alessandro G; Zardawi I; Grace J; McCarthy WH; Hersey P
Pathology; 1987 Oct; 19(4):339-46. PubMed ID: 3328139
[TBL] [Abstract][Full Text] [Related]
14. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi.
Kornstein MJ; Brooks JS; Elder DE
Cancer Res; 1983 Jun; 43(6):2749-53. PubMed ID: 6342758
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.
Pilch H; Günzel S; Schäffer U; Tanner B; Heine M
Cancer; 2000 Mar; 88(6):1370-7. PubMed ID: 10717619
[TBL] [Abstract][Full Text] [Related]
16. Ki67 antigen expression correlates with tumor progression and HLA-DR antigen expression in melanocytic lesions.
Moretti S; Massobrio R; Brogelli L; Novelli M; Giannotti B; Bernengo MG
J Invest Dermatol; 1990 Sep; 95(3):320-4. PubMed ID: 1696603
[TBL] [Abstract][Full Text] [Related]
17. Congenital nevi less than or equal to 10 cm as precursors to melanoma. 52 cases, a review, and a new conception.
Illig L; Weidner F; Hundeiker M; Gartmann H; Biess B; Leyh F; Paul E
Arch Dermatol; 1985 Oct; 121(10):1274-81. PubMed ID: 4037820
[TBL] [Abstract][Full Text] [Related]
18. Malignant melanoma in children and congenital melanocytic nevi: DNA content and cell cycle analysis by flow cytometry.
Alvarez-Mendoza A; Reyes-Esparza J; Ruiz-Maldonado R; Lopez-Corella E; Juarez-Herrera NC
Pediatr Dev Pathol; 2001; 4(1):73-81. PubMed ID: 11200494
[TBL] [Abstract][Full Text] [Related]
19. Distribution of congenital melanocytic naevi and congenital naevus-like naevi in a survey of 3406 Italian schoolchildren.
Gallus S; Naldi L;
Br J Dermatol; 2008 Aug; 159(2):433-8. PubMed ID: 18547318
[TBL] [Abstract][Full Text] [Related]
20. Proliferative Nodules vs Melanoma Arising in Giant Congenital Melanocytic Nevi During Childhood.
Vergier B; Laharanne E; Prochazkova-Carlotti M; de la Fouchardière A; Merlio JP; Kadlub N; Avril MF; Bodemer C; Lacoste C; Boralevi F; Taieb A; Ezzedine K; Fraitag S
JAMA Dermatol; 2016 Oct; 152(10):1147-1151. PubMed ID: 27486690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
